{"id":"NCT00486434","sponsor":"Nordic Bioscience A/S","briefTitle":"Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis","officialTitle":"A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Subjects With Knee Osteoarthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-05","primaryCompletion":"2010-09","completion":"2010-09","firstPosted":"2007-06-14","resultsPosted":"2012-06-28","lastUpdate":"2019-04-26"},"enrollment":1176,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Osteoarthritis"],"interventions":[{"type":"DRUG","name":"SMC021 Oral Calcitonin","otherNames":[]},{"type":"DRUG","name":"SMC021 Placebo","otherNames":[]}],"arms":[{"label":"1","type":"ACTIVE_COMPARATOR"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this Phase III study is to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of patients with osteoarthritis of the knee.","primaryOutcome":{"measure":"Joint Space Width (JSW) in the Medial Tibiofemoral Knee Joint in Signal Knee Measured by X-ray After 24 Months.","timeFrame":"Change from baseline to 24 months","effectByArm":[{"arm":"Active Arm","deltaMin":-0.188,"sd":0.5626},{"arm":"Placebo Arm","deltaMin":-0.198,"sd":0.5069}],"pValues":[]},"eligibility":{"minAge":"51 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":2},"locations":{"siteCount":9,"countries":["Czechia","Denmark","Estonia","Hong Kong","Poland","Romania"]},"refs":{"pmids":["32249039","31481084","29343266","25582279","20932224"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":100,"n":585},"commonTop":["Arthralgia","Hot flush","Back pain","Nausea","Hypertension"]}}